Neural cell engraftment therapy for sporadic Creutzfeldt-Jakob disease restores neuroelectrophysiological parameters in a cerebral organoid model.

Together with the previous animal studies, our results support that cell therapy may have some functional benefit for the treatment of human prion diseases.